Radiology, Vol 199, 761-766, Copyright © 1996 by Radiological Society of North America

ARTICLES

Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT

SK Mukherji, WE Drane, AA Mancuso, JT Parsons, WM Mendenhall and S Stringer
Department of Radiology, University of Florida College of Medicine, Gainesville 32610-0374, USA.

PURPOSE: To evaluate 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) single photon emission computed tomography (SPECT) in the detection of clinically occult primary tumors of the upper aerodigestive tract. MATERIALS AND METHODS: Eighteen patients with histologically proved cervical nodal metastasis from squamous cell carcinoma (SCC) underwent FDG SPECT; 17 also underwent computed tomography (CT) and one underwent magnetic resonance (MR) imaging. All 18 patients underwent direct panendoscopy and biopsy. Biopsy and imaging results were correlated. RESULTS: Among 11 histologically proved primary tumors, FDG SPECT depicted nine tumors; CT depicted four lesions. Five patients had abnormal FDG uptake with negative biopsy results. Among five patients with normal SPECT findings, biopsy results were positive in two and negative in three. FDG SPECT at the initial reading had sensitivity of 81%, specificity of 38%, positive predictive value of 64%, and negative predictive value of 60% for detection of occult primary tumors. CONCLUSION: FDG SPECT guidance of endoscopic biopsies in patients with occult primary SCCs of the head and neck has the potential to yield a higher rate of positive biopsy results than that traditionally expected from "blind" endoscopic procedures with "random" or "speculative" biopsy. FDG SPECT and CT are likely to remain complementary studies for the detection of occult primary tumors of the head and neck.

This article has been cited by other articles:

				C.-H. Baek, M. K. Chung, Y.-I. Son, J. Y. Choi, H.-J. Kim, Y. J. Yim, Y. H. Ko, J. Choi, J. K. Cho, and H.-S. Jeong Tumor Volume Assessment by 18F-FDG PET/CT in Patients with Oral Cavity Cancer with Dental Artifacts on CT or MR Images J. Nucl. Med., September 1, 2008; 49(9): 1422 - 1428. [Abstract] [Full Text] [PDF]

				S. K. Mukherji and C. R. Bradford Controversies: Is There a Role for Positron-Emission Tomographic CT in the Initial Staging of Head and Neck Squamous Cell Carcinoma? AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 243 - 245. [Full Text] [PDF]

				R.-F. Yen, R.-L. Hong, K.-Y. Tzen, M.-H. Pan, and T. H.-H. Chen Whole-Body 18F-FDG PET in Recurrent or Metastatic Nasopharyngeal Carcinoma J. Nucl. Med., May 1, 2005; 46(5): 770 - 774. [Abstract] [Full Text] [PDF]

				E. M. Rohren, T. G. Turkington, and R. E. Coleman Clinical Applications of PET in Oncology Radiology, May 1, 2004; 231(2): 305 - 332. [Abstract] [Full Text] [PDF]

				S. A. J. M. van Veen, A. J. M. Balm, R. A. Valdes Olmos, C. A. Hoefnagel, F. J. M. Hilgers, I. B. Tan, and F. A. Pameijer Occult Primary Tumors of the Head and Neck: Accuracy of Thallium 201 Single-Photon Emission Computed Tomography and Computed Tomography and/or Magnetic Resonance Imaging Arch Otolaryngol Head Neck Surg, April 1, 2001; 127(4): 406 - 411. [Abstract] [Full Text] [PDF]

				S. K. Mukherji, M. Gapany, D. Phillips, B. Neelon, S. O' O'Brien, W. McCartney, S. Buejenovich, J. S. Parekh, J. P. Noordzij, and M. Castillo Thallium-201 Single-Photon Emission CT versus CT for the Detection of Recurrent Squamous Cell Carcinoma of the Head and Neck AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1215 - 1220. [Abstract] [Full Text]

				O. S. AAssar, N. J. Fischbein, G. R. Caputo, M. J. Kaplan, D. C. Price, M. I. Singer, W. P. Dillon, and R. A. Hawkins Metastatic Head and Neck Cancer: Role and Usefulness of FDG PET in Locating Occult Primary Tumors Radiology, January 1, 1999; 210(1): 177 - 181. [Abstract] [Full Text]